Avantor (AVTR) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Avantor · Health Care · ref. ETF XLV · 86 calls · price $15.55
What the company does: Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services.
📈 Avantor (AVTR) stock price
$15.55+11.8% over range
Oct 14, 25low $7.41 · high $15.86Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
11% recommend buying · 9 analysts
📊 JPI status : Avantor has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 AVTR price target & analyst consensus — price $15.55
The price target · all analysts combined (9 targets)
Highest target · 1 firm of 9$16+2.9%
Median target · of 9 targets$15-3.5%
Lowest target · 1 firm of 9$11-29.3%
Current price$15.55
Where these 9 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
333%
$16 ↔ $17
Below
667%
$11 ↔ $15
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: UBS — 64% of its targets hit on this sector (124 calls tested). It aims for $16 (+2.9 %), call made on September 10, 2026, maturing on September 10, 2027 (34 d ago).
The 4 reliable analysts
$15.50-0.3 %
The 5 other firms
$15-3.5 %
How to read it: the 4 reliable firms are not filtered by optimism — 2 aim above the price, 2 below, hence their $15.50 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 9 ratings (last 6 months)
Strong Buy00%
Buy111%
Hold778%
Sell111%
Strong Sell00%
Go deeper on the analysts
🎯 AVTR price target all
All 86 calls, one by one, with our verdict on each firm.
→ See all 86 targets, analyst by analyst💡 The best analysts on AVTR most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in AVTR? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Avantor? The JPI assistant answers using our backtest data.
📈 Avantor fundamentals: valuation, margins & growth › open the full page
P/E —Net margin -8.8 %Revenue growth +0.5 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 9 %
2023
Rev −7%Profit −52%
2024
Rev −3%Profit +122%
2025
Rev −3%Profit −175%
🏛️ Avantor insider buying: who's buying and how much › open the full page
2 insiders bought2 buys / 6 mo $287k👥 Cluster buy
🔎 Detailed analyses
🏛️ Which US Congress members hold Avantor (AVTR)?
2 Congress members have disclosed AVTR buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
John James 1× · 43%Lisa McClain 1×
✅ Historical analyst reliability on AVTR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Jefferies ↗ | 100% | +33.4% | 2 |
| B of A Securities ↗ | 100% | +23.5% | 2 |
| Goldman Sachs ↗ | 80% | -2.2% | 5 |
| Citigroup ↗ | 67% | +39.7% | 6 |
| JP Morgan ↗ | 67% | -3.6% | 3 |
| UBS ↗ | 60% | +28.4% | 5 |
| Credit Suisse | 57% | +21.9% | 7 |
| Raymond James ↗ | 52% | +7.7% | 21 |
| TD Cowen ↗ | 50% | -22.1% | 2 |
| Morgan Stanley ↗ | 44% | +3.7% | 16 |
See the other 7 firms
| Stifel ↗ | 0% | -32.2% | 4 |
| Keybanc ↗ | 25% | -4.7% | 4 |
| Wells Fargo ↗ | 33% | -9.5% | 12 |
| Baird ↗ | 36% | -12.6% | 14 |
| Barclays ↗ | 38% | -8.3% | 29 |
| RBC Capital ↗ | 40% | -20.5% | 10 |
| Evercore ISI Group ↗ | 40% | -14.5% | 10 |
📊 What $1,000 invested in Avantor would be worth › open the full page
In short — $1,000 invested in Avantor 10 years ago would be worth $683 today, i.e. -5%/yr on average. Best year: 2020 (+53%), worst: 2022 (-50%). Price performance, excluding dividends.
If I'd invested $1,000 in Avantor
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $455 | -55% |
| 3 years ago | $469 | -53% |
| 5 years ago | $352 | -65% |
Return by year (Avantor)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -14% | $864 (-14%) |
| 2025 | -47% | $455 (-55%) |
| 2024 | -5% | $434 (-57%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Avantor
Loading news…
📋 All analyst calls on AVTR
Filtered on — · ✕ show all
Morgan Stanley ↗
Oct 13, 26
■ Equal-Weight neutral · not a buy · 🎯$15
Today : $15.55 — gap to target -4%
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
■ Hold neutral · not a buy · 🎯$17
Today : $15.55 — gap to target +9%
🎯 on AVTR : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
▼ Underweight · 🎯$15
Price at call : $15.35 — upside -2%
Today : $15.55 — upside -4%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
■ Neutral neutral · not a buy · 🎯$16
Price at call : $14.88 — gap to target +8%
Today : $15.55 — gap to target +3%
🎯 on AVTR : no call matured yet · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Sep 9, 27
matures : Sep 9, 27
Morgan Stanley ↗
Jul 30, 26
■ Equal-Weight neutral · not a buy · 🎯$14
Price at call : $13.78 — gap to target +2%
Today : $15.55 — gap to target -10%
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
RBC Capital ↗
Jul 30, 26
■ Sector Perform neutral · not a buy · 🎯$14
Price at call : $13.78 — gap to target +2%
Today : $15.55 — gap to target -10%
🎯 on AVTR : 50% (2 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
■ Hold neutral · not a buy · 🎯$15
Price at call : $13.78 — gap to target +9%
Today : $15.55 — gap to target -4%
🎯 on AVTR : no call matured yet · 📊 on Health : 48% · +12.3% (100 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Evercore ISI Group ↗
Jul 30, 26
■ In-Line neutral · not a buy · 🎯$14
Price at call : $13.78 — gap to target +2%
Today : $15.55 — gap to target -10%
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
See the other 78 calls, newest to oldest
Wells Fargo ↗
Jul 30, 26
▲ Overweight · 🎯$16
Price at call : $13.78 — upside +16%
Today : $15.55 — upside +3%
🎯 on AVTR : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
■ Neutral neutral · not a buy · 🎯$11
Price at call : $10.51 — gap to target +5%
Today : $15.55 — gap to target -29%
🎯 on AVTR : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
Evercore ISI Group ↗
Jul 6, 26
■ In-Line neutral · not a buy · 🎯$10.5
Price at call : $10.2 — gap to target +3%
Today : $15.55 — gap to target -32%
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▼ Underweight · 🎯$8
Price at call : $10.08 — upside -21%
Today : $15.55 — upside -49%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
■ Neutral neutral · not a buy · 🎯$9
Price at call : $7.96 — gap to target +13%
Today : $15.55 — gap to target -42%
🎯 on AVTR : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
Evercore ISI Group ↗
Apr 30, 26
■ In-Line neutral · not a buy · 🎯$8
Price at call : $7.96 — gap to target +1%
Today : $15.55 — gap to target -49%
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
▼ Underweight · 🎯$7
Price at call : $8.26 — upside -15%
Today : $15.55 — upside -55%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
Evercore ISI Group ↗
Apr 6, 26
■ In-Line neutral · not a buy · 🎯$8.5
Price at call : $8 — gap to target +6%
Today : $15.55 — gap to target -45%
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▼ Underweight · 🎯$8.5
Price at call : $8.17 — upside +4%
Today : $15.55 — upside -45%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
Wells Fargo ↗
Feb 13, 26
▲ Overweight · 🎯$14
Price at call : $9.05 — upside +55%
Today : $15.55 — upside -10%
🎯 on AVTR : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
■ Neutral neutral · not a buy · 🎯$11
Price at call : $9.2 — gap to target +20%
Today : $15.55 — gap to target -29%
🎯 on AVTR : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
■ Equal-Weight neutral · not a buy · 🎯$9
Price at call : $9.2 — gap to target -2%
Today : $15.55 — gap to target -42%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
■ Hold neutral · not a buy · 🎯$12
Price at call : $12.06 — gap to target -0%
Today : $15.55 — gap to target -23%
🎯 on AVTR : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
Evercore ISI Group ↗
Jan 5, 26
■ In-Line neutral · not a buy · 🎯$12
Price at call : $12.27 — gap to target -2%
Today : $15.55 — gap to target -23%
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
▼ Underperform · 🎯$9
Price at call : $11.1 — upside -19%
Today : $15.55 — upside -42%
🎯 on AVTR : no call matured yet · 📊 on Health : 48.3% · +10.7% (116 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
Evercore ISI Group ↗
Oct 30, 25
▲ Outperform · 🎯$14
Price at call : $11.82 — upside +18%
Today : $15.55 — upside -10%
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $11.05 — gap to target +9%
Today : $15.55 — gap to target -23%
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
■ Neutral neutral · not a buy · 🎯$12
Price at call : $11.05 — gap to target +9%
Today : $15.55 — gap to target -23%
🎯 on AVTR : 100% (1 call matured) · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
▲ Outperform · 🎯$17
Price at call : $15.4 — upside +10%
Today : $15.55 — upside +9%
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : Oct 24, 26
matures : Oct 24, 26
Raymond James ↗
Oct 16, 25
▲ Outperform · 🎯$16
Price at call : $14.78 — upside +8%
Today : $15.55 — upside +3%
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
in progress (365j)
matures : Oct 16, 26
matures : Oct 16, 26
▲ Overweight · 🎯$15
Price at call : $14.29 — upside +5%
Today : $15.55 — upside -4%
Expected +5% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
+10.6%
stock +11% · XLV +16%
matured Oct 2, 26
■ Hold neutral · not a buy · 🎯$12
Price at call : $11.64 — gap to target +3%
Today : $15.55 — gap to target -23%
🎯 on AVTR : no call matured yet · 📊 on Health : 48% · +12.3% (100 calls)
in progress (365j)
matures : Aug 4, 26
matures : Aug 4, 26
▲ Overweight · 🎯$14
Price at call : $11.64 — upside +20%
Today : $15.55 — upside -10%
Expected +20% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 100% (1 call matured) · 📊 on Health : 49% · +7.1% (147 calls)
+14.8%
stock +15% · XLV +24%
matured Aug 4, 26
Evercore ISI Group ↗
Aug 4, 25
▲ Outperform · 🎯$16
Price at call : $11.64 — upside +37%
Today : $15.55 — upside +3%
Expected +37% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
+14.8%
stock +15% · XLV +24%
matured Aug 4, 26
Morgan Stanley ↗
Aug 4, 25
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $11.64 — gap to target +3%
Today : $15.55 — gap to target -23%
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Aug 4, 26
matures : Aug 4, 26
▲ Overweight · 🎯$13
Price at call : $11.64 — upside +12%
Today : $15.55 — upside -16%
Expected +12% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
+14.8%
stock +15% · XLV +24%
matured Aug 4, 26
Wells Fargo ↗
Aug 4, 25
▲ Overweight · 🎯$16
Price at call : $11.64 — upside +37%
Today : $15.55 — upside +3%
Expected +37% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
+14.8%
stock +15% · XLV +24%
matured Aug 4, 26
RBC Capital ↗
Aug 4, 25
▲ Outperform · 🎯$17
Price at call : $11.64 — upside +46%
Today : $15.55 — upside +9%
Expected +46% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (2 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+14.8%
stock +15% · XLV +24%
matured Aug 4, 26
Raymond James ↗
Aug 4, 25
▲ Outperform · 🎯$14
Price at call : $11.3 — upside +24%
Today : $15.55 — upside -10%
Expected +24% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+21.1%
stock +21% · XLV +22%
matured Aug 4, 26
▲ Outperform · 🎯$15
Price at call : $11.3 — upside +33%
Today : $15.55 — upside -4%
Expected +33% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
+21.1%
stock +21% · XLV +22%
matured Aug 4, 26
▲ Outperform · 🎯$18
Price at call : $13.99 — upside +29%
Today : $15.55 — upside +16%
Expected +29% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
-11.2%
stock -11% · XLV +24%
matured Jul 28, 26
Goldman Sachs ↗
Apr 29, 25
■ Neutral neutral · not a buy · 🎯$14
Price at call : $12.69 — gap to target +10%
Today : $15.55 — gap to target -10%
🎯 on AVTR : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Apr 29, 26
matures : Apr 29, 26
RBC Capital ↗
Apr 28, 25
▲ Outperform · 🎯$20
Price at call : $12.69 — upside +58%
Today : $15.55 — upside +29%
Expected +58% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (2 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
-38.1%
stock -38% · XLV +3%
matured Apr 28, 26
■ Hold neutral · not a buy · 🎯$14
Price at call : $12.69 — gap to target +10%
Today : $15.55 — gap to target -10%
🎯 on AVTR : no call matured yet · 📊 on Health : 48% · +12.3% (100 calls)
in progress (365j)
matures : Apr 28, 26
matures : Apr 28, 26
▲ Overweight · 🎯$15
Price at call : $12.49 — upside +20%
Today : $15.55 — upside -4%
Expected +20% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
-37.1%
stock -37% · XLV +4%
matured Apr 28, 26
Morgan Stanley ↗
Apr 28, 25
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $12.49 — gap to target +20%
Today : $15.55 — gap to target -4%
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Apr 28, 26
matures : Apr 28, 26
▲ Outperform · 🎯$17
Price at call : $12.49 — upside +36%
Today : $15.55 — upside +9%
Expected +36% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
-37.1%
stock -37% · XLV +4%
matured Apr 28, 26
Wells Fargo ↗
Apr 17, 25
▲ Overweight · 🎯$22
Price at call : $14.96 — upside +47%
Today : $15.55 — upside +41%
Expected +47% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
-43.2%
stock -43% · XLV +11%
matured Apr 17, 26
▲ Overweight · 🎯$18
Price at call : $15.22 — upside +18%
Today : $15.55 — upside +16%
Expected +18% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
-46.3%
stock -46% · XLV +8%
matured Apr 10, 26
■ Neutral neutral · not a buy · 🎯$18
Price at call : $15.75 — gap to target +14%
Today : $15.55 — gap to target +16%
🎯 on AVTR : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Mar 4, 26
matures : Mar 4, 26
Morgan Stanley ↗
Feb 10, 25
▲ Overweight · 🎯$25
Price at call : $18.39 — upside +36%
Today : $15.55 — upside +61%
Expected +36% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 0% (1 call matured) · 📊 on Health : 42% · -0.8% (200 calls)
-47.6%
stock -48% · XLV +7%
matured Feb 10, 26
Raymond James ↗
Feb 10, 25
▲ Outperform · 🎯$24
Price at call : $18.39 — upside +31%
Today : $15.55 — upside +54%
Expected +31% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-47.6%
stock -48% · XLV +7%
matured Feb 10, 26
▲ Overweight · 🎯$23
Price at call : $19.01 — upside +21%
Today : $15.55 — upside +48%
Expected +21% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
-41.3%
stock -41% · XLV +6%
matured Feb 10, 26
▲ Overweight · 🎯$26
Price at call : $22.01 — upside +18%
Today : $15.55 — upside +67%
Expected +18% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
-49.4%
stock -49% · XLV +6%
matured Feb 3, 26
Raymond James ↗
Jan 21, 25
▲ Outperform · 🎯$26
Price at call : $22.1 — upside +18%
Today : $15.55 — upside +67%
Expected +18% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-44.6%
stock -45% · XLV +11%
matured Jan 21, 26
▲ Outperform · 🎯$26
Price at call : $22.64 — upside +15%
Today : $15.55 — upside +67%
Expected +15% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
-33.4%
stock -33% · XLV -2%
matured Oct 28, 25
▲ Overweight · 🎯$25
Price at call : $22.64 — upside +10%
Today : $15.55 — upside +61%
Expected +10% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
-33.3%
stock -33% · XLV -2%
matured Oct 25, 25
▲ Overweight · 🎯$28
Price at call : $27.65 — upside +1%
Today : $15.55 — upside +80%
Expected +1% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
-50.1%
stock -50% · XLV -11%
matured Jul 29, 25
▲ Outperform · 🎯$27
Price at call : $26.25 — upside +3%
Today : $15.55 — upside +74%
Expected +3% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
-46.6%
stock -47% · XLV -10%
matured Jul 29, 25
Evercore ISI Group ↗
Jul 2, 24
▲ Outperform · 🎯$27
Price at call : $21.01 — upside +29%
Today : $15.55 — upside +74%
Expected +29% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
-33.9%
stock -34% · XLV -5%
matured Jul 2, 25
▲ Overweight · 🎯$25
Price at call : $20.77 — upside +20%
Today : $15.55 — upside +61%
Expected +20% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
-35.2%
stock -35% · XLV -7%
matured Jun 28, 25
▲ Outperform · 🎯$26
Price at call : $24.08 — upside +8%
Today : $15.55 — upside +67%
Expected +8% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
-47.3%
stock -47% · XLV -1%
matured Apr 29, 25
▲ Overweight · 🎯$30
Price at call : $25.55 — upside +17%
Today : $15.55 — upside +93%
Expected +17% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
-40.4%
stock -40% · XLV -3%
matured Apr 10, 25
Evercore ISI Group ↗
Apr 4, 24
▲ Outperform · 🎯$28
Price at call : $25.87 — upside +8%
Today : $15.55 — upside +80%
Expected +8% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
-41.1%
stock -41% · XLV -6%
matured Apr 4, 25
▲ Outperform · 🎯$26
Price at call : $23.76 — upside +9%
Today : $15.55 — upside +67%
Expected +9% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
-27.0%
stock -27% · XLV -1%
matured Feb 14, 25
▲ Overweight · 🎯$27
Price at call : $24.05 — upside +12%
Today : $15.55 — upside +74%
Expected +12% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
-25.7%
stock -26% · XLV -0%
matured Feb 14, 25
Raymond James ↗
Jan 26, 24
▲ Outperform · 🎯$26
Price at call : $22.66 — upside +15%
Today : $15.55 — upside +67%
Expected +15% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-0.8%
stock -1% · XLV +6%
matured Jan 25, 25
Evercore ISI Group ↗
Jan 4, 24
▲ Outperform · 🎯$26
Price at call : $21.88 — upside +19%
Today : $15.55 — upside +67%
Expected +19% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
-0.5%
stock -1% · XLV -0%
matured Jan 3, 25
▲ Overweight · 🎯$24
Price at call : $21.17 — upside +13%
Today : $15.55 — upside +54%
Expected +13% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 25% (12 calls matureds) · 📊 on Health : 48.3% · +1.1% (203 calls)
+6.0%
stock +6% · XLV +8%
matured Dec 10, 24
Raymond James ↗
Oct 30, 23
▲ Outperform · 🎯$22.5
Price at call : $17.15 — upside +31%
Today : $15.55 — upside +45%
Expected +31% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+31.3%
stock +31% · XLV +20%
matured Oct 29, 24
▲ Outperform · 🎯$22
Price at call : $20.89 — upside +5%
Today : $15.55 — upside +41%
Expected +5% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
+28.1%
stock +28% · XLV +12%
matured Jul 30, 24
Raymond James ↗
Jul 31, 23
▲ Outperform · 🎯$25
Price at call : $20.57 — upside +22%
Today : $15.55 — upside +61%
Expected +22% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+34.4%
stock +34% · XLV +12%
matured Jul 30, 24
Evercore ISI Group ↗
Jul 6, 23
▲ Outperform · 🎯$23
Price at call : $20.73 — upside +11%
Today : $15.55 — upside +48%
Expected +11% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
+1.0%
stock +1% · XLV +12%
matured Jul 5, 24
▲ Outperform · 🎯$24
Price at call : $20.23 — upside +19%
Today : $15.55 — upside +54%
Expected +19% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
+19.8%
stock +20% · XLV +5%
matured Apr 30, 24
Raymond James ↗
May 1, 23
▲ Outperform · 🎯$28
Price at call : $20.23 — upside +38%
Today : $15.55 — upside +80%
Expected +38% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+19.8%
stock +20% · XLV +5%
matured Apr 30, 24
Evercore ISI Group ↗
Apr 4, 23
▲ Outperform · 🎯$28
Price at call : $20.82 — upside +34%
Today : $15.55 — upside +80%
Expected +34% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
+20.6%
stock +21% · XLV +7%
matured Apr 3, 24
▲ Outperform · 🎯$27
Price at call : $23.42 — upside +15%
Today : $15.55 — upside +74%
Expected +15% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
+1.0%
stock +1% · XLV +9%
matured Feb 6, 24
Raymond James ↗
Feb 6, 23
▲ Outperform · 🎯$30
Price at call : $23.42 — upside +28%
Today : $15.55 — upside +93%
Expected +28% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+1.0%
stock +1% · XLV +9%
matured Feb 6, 24
Evercore ISI Group ↗
Feb 3, 23
▲ Outperform · 🎯$28
Price at call : $23.42 — upside +20%
Today : $15.55 — upside +80%
Expected +20% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
+1.3%
stock +1% · XLV +8%
matured Feb 3, 24
Raymond James ↗
Oct 31, 22
▲ Outperform · 🎯$26
Price at call : $19.98 — upside +30%
Today : $15.55 — upside +67%
Expected +30% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-12.9%
stock -13% · XLV -6%
matured Oct 31, 23
▲ Outperform · 🎯$29
Price at call : $20.17 — upside +44%
Today : $15.55 — upside +86%
Expected +44% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
-13.6%
stock -14% · XLV -6%
matured Oct 31, 23
Raymond James ↗
Oct 18, 22
▲ Outperform · 🎯$27
Price at call : $20.61 — upside +31%
Today : $15.55 — upside +74%
Expected +31% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+0.9%
stock +1% · XLV +3%
matured Oct 18, 23
▲ Outperform · 🎯$32
Price at call : $21.09 — upside +52%
Today : $15.55 — upside +106%
Expected +52% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 33% (12 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
-2.1%
stock -2% · XLV +4%
matured Oct 6, 23
Raymond James ↗
Aug 1, 22
▲ Outperform · 🎯$36
Price at call : $29.49 — upside +22%
Today : $15.55 — upside +132%
Expected +22% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-29.2%
stock -29% · XLV +2%
matured Aug 1, 23
Evercore ISI Group ↗
Apr 18, 22
▲ Outperform · 🎯$42
Price at call : $31.67 — upside +33%
Today : $15.55 — upside +170%
Expected +33% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
-34.7%
stock -35% · XLV -3%
matured Apr 18, 23
Raymond James ↗
Apr 18, 22
▲ Outperform · 🎯$40
Price at call : $31.01 — upside +29%
Today : $15.55 — upside +157%
Expected +29% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 50% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-34.1%
stock -34% · XLV -3%
matured Apr 18, 23
Evercore ISI Group ↗
Apr 4, 22
▲ Outperform · 🎯$42
Price at call : $31.62 — upside +33%
Today : $15.55 — upside +170%
Expected +33% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
-34.2%
stock -34% · XLV -3%
matured Apr 4, 23
Evercore ISI Group ↗
Sep 9, 21
▲ Outperform · 🎯$42
Price at call : $42.33 — upside -1%
Today : $15.55 — upside +170%
Expected -1% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on AVTR : 40% (10 calls matureds) · 📊 on Health : 39.1% · -4.9% (46 calls)
-38.5%
stock -38% · XLV -1%
matured Sep 9, 22
Frequently asked questions
Should I buy Avantor stock?
This isn't buy advice. For Avantor, the analyst consensus is "Hold", with an average price target of $15.00 (-4% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Avantor). We show the numbers — you decide.
Is it too late to buy Avantor? How high can it go?
The most bullish analyst target on Avantor is $16.00 (+3% above today's price); the average is $15.00. That's the upside they see. Check how reliable those analysts have actually been on Avantor on our site before trusting it.
Is Avantor still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Avantor, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Avantor? The case for and against
The arguments for and against, one by one, from the numbers: why invest in AVTR (and why hesitate).
What has Avantor's past performance been?
Historical returns and a "how much if I had invested" calculator: AVTR performance & returns.
What is the best month to buy AVTR?
The 12 months ranked by the stock's past returns: best & worst month to buy AVTR.
Are insiders buying AVTR stock?
Executives' and large holders' buys and sells, decoded: insider buying on AVTR.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX